Recent Company News

• 05:50 PM ET Apr 15, 2026
  

  Ryman Healthcare upgraded to outperform from neutral at Macquarie (NZ$2.14, 0.00)

• 04:34 PM ET Apr 14, 2026
  

  Ryman Healthcare issues Q4 trading update, reports 331 sales of occupation right agreements (NZ$2.07, 0.00)

• 12:59 AM ET Apr 13, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (46 total)

• 12:01 AM ET Mar 31, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (43 total)

• 11:57 PM ET Mar 29, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (72 total)

• 07:51 PM ET Feb 03, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 08:02 PM ET Feb 02, 2026
  

  Ryman Healthcare releases Investor Day presentation; targets return to sustainable dividends in FY28 with payout policy of 20-50% CFEO/share (NZ$2.75, -0.04)

• 02:39 PM ET Jan 14, 2026
  

  Ryman Healthcare issues Q3 trading update, reports 375 sales of occupation right agreements (NZ$2.99, 0.00)

• 02:34 PM ET Dec 09, 2025
  

  Insider transaction: Ryman Healthcare CEO Naomi James discloses purchase of 87K shares -- Appendix 3Y (NZ$2.87, 0.00)

• 05:12 PM ET Dec 03, 2025
  

  Ryman Healthcare upgraded to neutral from underweight at Jarden (NZ$2.90, -0.01)